NCT02294071

Brief Summary

This study will examine in detail the immediate effects of three common treatments given to children with fevers to lower their temperature. Each child will be given either ibuprofen, acetaminophen, or a combination, and their temperature monitored at five-minute intervals. The temperature-lowering effects of each treatment will be compared to evaluate which is most effective.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 19, 2014

Completed
12 days until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Last Updated

November 19, 2014

Status Verified

November 1, 2014

Enrollment Period

11 months

First QC Date

November 17, 2014

Last Update Submit

November 17, 2014

Conditions

Keywords

acetaminophenibuprofen

Outcome Measures

Primary Outcomes (1)

  • temperature reduction from baseline

    change in temperature from baseline at time of drug administration and at five minute intervals afterward for a minimum of one hour, maximum 4 hours

    4 hours

Study Arms (3)

acetaminophen

EXPERIMENTAL

acetaminophen 15mg/kg (max 975mg)

Drug: Acetaminophen

ibuprofen

EXPERIMENTAL

ibuprofen 10mg/kg (max 600mg)

Drug: Ibuprofen

combination

EXPERIMENTAL

acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)

Drug: IbuprofenDrug: Acetaminophen

Interventions

oral liquid ibuprofen 10mg/kg (maximum 600 mg)

Also known as: Advil
combinationibuprofen

oral liquid acetaminophen 15mg/kg (max 975mg)

Also known as: Tylenol
acetaminophencombination

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • fever between 38 and 41 Celsius (inclusive) on presentation to ER
  • assessment by treating physician that patient requires antipyretic treatment

You may not qualify if:

  • known allergy or hypersensitivity to either study medication
  • received any antipyretic medication in past eight hours
  • patient requires admission to hospital
  • co-morbidities indicating increased risk of complication
  • assessment by treating physician that patient is medically unsuitable for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (16)

  • Mullins ME, Empey M, Jaramillo D, Sosa S, Human T, Diringer MN. A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients. Neurocrit Care. 2011 Dec;15(3):375-8. doi: 10.1007/s12028-011-9533-8.

    PMID: 21503807BACKGROUND
  • Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211.

    PMID: 22373120BACKGROUND
  • Section on Clinical Pharmacology and Therapeutics; Committee on Drugs; Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011 Mar;127(3):580-7. doi: 10.1542/peds.2010-3852. Epub 2011 Feb 28.

    PMID: 21357332BACKGROUND
  • Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Cochrane Database Syst Rev. 2013 Oct 30;2013(10):CD009572. doi: 10.1002/14651858.CD009572.pub2.

    PMID: 24174375BACKGROUND
  • D Leduc SWCPSCPC. Temperature measurement in pediatrics. Canadian Pediatric Society. 2013.

    BACKGROUND
  • Mayoral CE, Marino RV, Rosenfeld W, Greensher J. Alternating antipyretics: is this an alternative? Pediatrics. 2000 May;105(5):1009-12. doi: 10.1542/peds.105.5.1009.

    PMID: 10790455BACKGROUND
  • Vyas FI, Rana DA, Patel PM, Patel VJ, Bhavsar RH. Randomized comparative trial of efficacy of paracetamol, ibuprofen and paracetamol-ibuprofen combination for treatment of febrile children. Perspect Clin Res. 2014 Jan;5(1):25-31. doi: 10.4103/2229-3485.124567.

    PMID: 24551584BACKGROUND
  • Allan GM, Ivers N, Shevchuk Y. Treatment of pediatric fever: Are acetaminophen and ibuprofen equivalent? Can Fam Physician. 2010 Aug;56(8):773. No abstract available.

    PMID: 20705883BACKGROUND
  • Erlewyn-Lajeunesse MD, Coppens K, Hunt LP, Chinnick PJ, Davies P, Higginson IM, Benger JR. Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch Dis Child. 2006 May;91(5):414-6. doi: 10.1136/adc.2005.087874. Epub 2006 Feb 7.

    PMID: 16464962BACKGROUND
  • Hay AD, Costelloe C, Redmond NM, Montgomery AA, Fletcher M, Hollinghurst S, Peters TJ. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008 Sep 2;337:a1302. doi: 10.1136/bmj.a1302.

    PMID: 18765450BACKGROUND
  • Kramer LC, Richards PA, Thompson AM, Harper DP, Fairchok MP. Alternating antipyretics: antipyretic efficacy of acetaminophen versus acetaminophen alternated with ibuprofen in children. Clin Pediatr (Phila). 2008 Nov;47(9):907-11. doi: 10.1177/0009922808319967. Epub 2008 Jun 6.

    PMID: 18539869BACKGROUND
  • Paul IM, Sturgis SA, Yang C, Engle L, Watts H, Berlin CM Jr. Efficacy of standard doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children. Clin Ther. 2010 Dec;32(14):2433-40. doi: 10.1016/j.clinthera.2011.01.006.

    PMID: 21353111BACKGROUND
  • Brown RD, Kearns GL, Wilson JT. Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm. 1998 Oct;26(5):559-79. doi: 10.1023/a:1023225217108.

    PMID: 10205771BACKGROUND
  • Kauffman RE, Sawyer LA, Scheinbaum ML. Antipyretic efficacy of ibuprofen vs acetaminophen. Am J Dis Child. 1992 May;146(5):622-5. doi: 10.1001/archpedi.1992.02160170102024.

    PMID: 1621668BACKGROUND
  • Temple AR, Temple BR, Kuffner EK. Dosing and antipyretic efficacy of oral acetaminophen in children. Clin Ther. 2013 Sep;35(9):1361-75.e1-45. doi: 10.1016/j.clinthera.2013.06.022. Epub 2013 Aug 23.

    PMID: 23972576BACKGROUND
  • Troconiz IF, Armenteros S, Planelles MV, Benitez J, Calvo R, Dominguez R. Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet. 2000 Jun;38(6):505-18. doi: 10.2165/00003088-200038060-00004.

    PMID: 10885587BACKGROUND

MeSH Terms

Conditions

Fever

Interventions

IbuprofenAcetaminophen

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Study Officials

  • Michael J Rieder, MD

    Western University, Canada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael J Rieder, MD

CONTACT

Lauren Faught, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 17, 2014

First Posted

November 19, 2014

Study Start

December 1, 2014

Primary Completion

November 1, 2015

Last Updated

November 19, 2014

Record last verified: 2014-11